FDA Resources

FDA Q&A on Vioxx (Sept. 30, 2004)
FDA Advisory Letter on Vioxx (Sept. 30, 2004)
FDA Vioxx Warning Letter (Sept. 17, 2001)

Photo: Supreme Court, Gavel & Law Books, Scales, various pill images

Lieff Cabraser Heimann & Bernstein, LLP

E-mail: mail
Firm Website: http://www.lieffcabraser.com

Home | Disclaimer | Our Firm | Site Map | Contact Us

Trademark Notice

"Vioxx" is a registered trademark of Merck. Lieff Cabraser Heimann & Bernstein, LLP is in no way affiliated with Merck, and the Vioxx trademark is used solely for informational purposes.

"Banned Report on Vioxx Published" Los Angeles Times, Jan. 25, 2005

A report on Vioxx risks previously blocked by the FDA was published online Monday after the agency withdrew its opposition. The study found that as many as 140,000 cases of heart disease in the United States and as many as 56,000 deaths were caused by the painkiller Vioxx during the five years that it was on the market.

To read more press articles on the Vioxx recall and Vioxx class action lawsuit, click here.